Magnetic resonance tomography: Potentials of molecular imaging;Magnet-resonanz-tomographie: Möglichkeiten der molekularen bildgebung

Zeitschrift fur Medizinische Physik

Volumn 15, Issue 3, 2005, Pages 155-162

  Hiller, Karl Heinz ^a   Faber, Cornelius ^a   Neuberger, Thomas ^a   Köhler, Sascha ^a   Stroh, Albrecht ^b   Zimmer, Claus ^c   Jakob, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Angiogenesis; Apoptosis; Atherosclerosis; Contrast agents; Magnetic resonance; Molecular imaging; Thrombosis

Indexed keywords

CONTRAST MEDIUM;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; IMAGE QUALITY; LABORATORY; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; STEM CELL; THROMBOSIS;

EID: 24644522748     PISSN: 09393889     EISSN: None     Source Type: Journal    
DOI: 10.1078/0939-3889-00266     Document Type: Article

References (25)

1. Schmitz, S, Taupitz, M, Wagner, S et al.: Iron-Oxide-Enhanced Magnetic Resonance Imaging of Atherosclerotic Plaques: Postmortem Analysis of Accuracy, Inter-Observer Agreement, and Pitfalls. Invest Radiol. 37 (2002) 405-411
2. Lanza, GM, Lamerichs, R, Caruthers, S, Wickline, SA: Molecular Imaging in MR with targeted paramagnetic nanoparticles. MEDICAMUNDI 47/1 (2003).
3. Winter, P, Chen, J, Song, S-K, Fuhrhop, R, Wickline, S, Lanza, GM: Relaxivities of Paramagnetic Nanoparticle Contrast Agents For Targeted Molecular Imaging. Proc Intl Soc Mag Reson Med 9 (2001) 54.
4. Köhler, S, Maier, J, Hiller, KH, Haase, A, Jakob, PM: The sensitivity of TrueFisp to mesoscopic field inhomogeneities. Proc Intl Soc Mag Reson Med 11 (2003) 977.
5. Foster-Gareau, P, Heyn, C, Alejski, A, Rutt, BK: Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 49(5) (2003) 968-971
6. Coristine, AJ, Foster, P, Deoni, SC, Heyn, C, Rutt, BK: Positive Contrast Labelling of SPIO Loaded Cells in Cell Samples and Spinal Cord Injury. Proc Intl Soc Mag Reson Med 11 (2004) 163.
7. Jaffer, FA, Tung, CH, Houng, AK, O'Laughin, T, Reed, GL, Weissleder, R: MRI of blood coagulation factor XIII activity using a novel derivatized caged iron oxide nanoparticle (F13-CLIO). Mol Imaging 1 (2002) 217-218
8. Yu, X, Song, S-K, Chen, J, Scott, MJ et al.: High-Resolution MRI Characterization of Human Thrombus using a Novel Fibrin-Targeted Paramagnetic Nanoparticle Contrast Agent. Magn Reson Med 44 (2000) 867/872
9. Flacke, S, Fischer, S, Scott et al.: A Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques. Circulation 104 (2001) 1280/1285
10. Botnar, RM, Perez, AS, Witte, S, Wiethoff, AJ, Laredo, J, Hamilton, J, Quist, W, Parsons, EC Jr, Vaidya, A, Kolodziej, A, Barrett, JA, Graham, PB, Weisskoff, RM, Manning, WJ, Johnstone, MT: In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109(16) (2004) 2023-2029
11. Ruehm, SG, Corot, C, Vogt, P, Kolb, S, Debatin, JF: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103 (2001) 415-422
12. Dardzinski, BJ, Schmithorst, VJ, Holland, SK, Boivin, GP, Imagawa, T, Watanabe, S, Lewis, JM, Hirsch, R: Magn Res Imaging 19 (2001) 1209-1216
13. Kraitchman, DL, Heldman, AW, Atalar, E, Amado, LC, Martin, BJ, Pittenger, MF, Hare, JM, Bulte, JWM: In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107 (2003) 2290-2293
14. Stroh, A, Faber, C, Neuberger, T, Lorenz, P, Sieland, U, Jakob, PM, Webb, A, Pilgrimm, H, Schober, R, Pohl, E, Zimmer, C: In vivo detection limits of magnetically labeled embryonic stem cells in the rat brain using high-field (17.6 T) magnetic resonance imaging. Neuroimage 24(3) (2005) 635-645
15. Anderson, SA, Rader, RK, Westlin, WF et al.: Magnetic Resonance Contrast Enhancement of Neovasculature with Alpha (V)Beta(3)-Targeted Nanoparticles. Magn Reson Med 44 (2000) 433-439
16. 3-Targeted Nanoparticles. Mol Imaging 1 (2002) 218
17. 3-Targeted Paramagnetic Nanoparticles. Mol Imaging 1 (2002) 78
18. 3-targeted nanoparticles. Mol Imaging 1 (2002) 190
19. 3-targeted magnetic resonance imaging. Nat Med 4 (1998) 623-626
20. Zhao, M, Beauregard, DA, Loizou, L, Davletov, B, Brindle, KM: Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7(11) (2001) 1241-1244
21. Schellenberger, EA, Bogdanov, A Jr, Hogemann, D, Tait, J, Weissleder, R, Josephson, L: Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI Mol Imaging. Mol Imaging 1(2) (2002) 102-107
22. Hiller, KH, Waller, C, Köhler, S, Peymann, T, Nahrendorf, M, Schulze, B, Bauer, WR, Jakob, PM: Magnetic resonance molecular imaging: detecting apoptosis in the isolated rat heart using Gd-labeled annexin-V. Abstract ESMRMB 2004
23. Aime, S, Cabella, C, Colombatta, S, Crich, SG, Gianolia, E, Maggioni, F: Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 16 (2002) 394-406
24. Louie, AY, Hüber, MM, Ahrens, ET, Rothbächer, U, Moats, R, Jacobs, RE, Fraser, SE, Meade, TJ: In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotech 18 (2000) 321-325
25. Weinmann, HJ, Ebert, W, Misselwitz, B, Schmitt-Willich, H: Tissue-specific MR contrast agents. Eur J Radiol 46 (2003) 33-44